Cache Dna
6 known investors
Cache develops biopreservation reagents that enable room-temperature storage and access for DNA, RNA, and other biosamples without cold-chain infrastructure. Its ambient-storage platform serves research, drug development, diagnostics, and personalized medicine applications.
BiotechDeep TechHealthtech
Investors Β· 6
.jpeg){kind=logo}
Non-dilutive funding Β· 1 SBIR/STTR award
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2022 | $255.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Cache Dna do?
- Cache develops biopreservation reagents that enable room-temperature storage and access for DNA, RNA, and other biosamples without cold-chain infrastructure. Its ambient-storage platform serves research, drug development, diagnostics, and personalized medicine applications.
- Who are Cache Dna's investors?
- Cache Dna's investors include Fifty Years, HAWKTAIL, Juniper, LifeX Ventures, Trousdale Ventures, Valkyrie.